Drugs Health Pharma

Merck’s pill to treat rare type of tumour gets approval from US regulator

HQ Team May 15, 2025: Merck & Co. got approval from the US Food and Drug Administration for a pill to treat a.

Read More
Drugs Health Pharma

Novo Nordisk, Septerna in $2.2b deal to develop oral molecules

HQ Team May 14, 2025: Novo Nordisk and Septerna, Inc., have inked a $2.2 billion global collaboration and licensing pact to develop oral.

Read More
Drugs Health Pharma

GSK to buy Boston’s lead drug asset for liver disease for $2 billion in cash

HQ Team May 14, 2025: GSK Plc will acquire Boston Pharmaceutical’s investigational lead asset, efimosfermin alfa, to treat serious liver diseases, for $2.

Read More
Drugs Health Research

Spanish researchers redesign protein to improve lifespan, brain power in mice

HQ Team May 14, 2025: Mice treated with a special protein called Klotho for a year showed marked improvements in longevity and physical.

Read More
Drugs Health Medical

Security Council must act to prevent ‘genocide’ in Gaza: UN relief chief says

HQ Team May 14, 2025: UN relief chief Tom Fletcher has told the Security Council that the ambassadors must finally act decisively “to.

Read More
Drugs Health Research

Antibiotic use in girls may trigger early onset of puberty: Study

 HQ Team May 13, 2025: Antibiotic use in girls in the first year of life, especially in the first three months, may be.

Read More
Drugs Research

AstraZeneca’s blood cancer combination drug shows positive results in end trial

HQ Team May 13, 2025: AstraZeneca’s POTOMAC Phase III trial has demonstrated that combining Imfinzi (durvalumab) with standard Bacillus Calmette-Guérin (BCG) therapy significantly improves disease-free survival (DFS) in patients.

Read More
Climate Drugs Health

AstraZeneca’s environment-friendly inhaler gets UK regulator’s nod

HQ Team May 12, 2025: British-Swedish AstraZeneca Plc’s medicine used for adults with chronic obstructive pulmonary disease has been approved in the UK.

Read More
Drugs Health Pharma

Merck Animal Health to invest $895 million to expand facility in US

HQ Team May 8, 2025: Merck Animal Health will invest $895 million in its US facility to develop novel parasiticides and therapeutics, and.

Read More
Drugs Health

India grapples with thalassaemia crisis with 42 million carriers

HQ Team May 8, 2025: As the world observes World Thalassaemia Day on May 8, India faces a harsh reality—it is often called.

Read More